This suggests not only that COX-2 may be involved in the occurrence and development of lymph node metastasis and in disease progression, but also that it may have potential in assessing prognosis and in treatment decisions. This evidence concerns the gene PTGS2 and metastatic malignant neoplasm in the lymph nodes.